Vials and medical syringes with Covid-19 vaccine stickers with the logos of the American pharmaceutical company Pfizer and the German biotechnology company BioNTech.
Vincent Kalut | Photonews | Getty Images
The U.S. Food and Drug Administration said Wednesday that extra doses from vials containing Pfizer Covid-19 vaccine could be used after pharmacists discarded vaccine doses due to a labeling disorder.
Stat News previously reported that hospital pharmacists were in a position to discard every six doses of the first Pfizer-BioNTech Covid-19 vaccine distributed this week in the United States due to labeling disruptions.
According to the labeling, there are reportedly five doses in Pfizer vials, but press reports suggest pharmacists have found a way to administer the sixth or even seventh dose. The extra dose had to be discarded without the express approval of the manufacturer.
“Currently, given the public health emergency, the FDA is advising that it is acceptable to use each full vial (sixth, possibly one-seventh) of each vial until the problem is resolved,” the FDA representative said. sent a statement by e-mail.
“However, as vials are preservative-free, it is critical to note that additional residual products that do not represent a full dose should not be combined from multiple vials to create one,” the statement added.
The introduction of the first tranche of 2.9 million doses of the newly authorized vaccine by Pfizer and German partner BioNTech SE continued for a third full day, with deliveries to another 66 distribution centers in the United States.
Moderna Inc.’s second vaccine this week could get emergency use from the FDA.
An additional 2 million doses of Pfizer vaccine and 5.9 million doses of Moderna vaccine could be distributed next week, Alex Azar, secretary of the U.S. Department of Health and Human Services, said in a conference call on Wednesday. For each person vaccinated, two doses of vaccine are needed, three or four weeks apart.